Biogen Inc.
BIIB
$147.37
$3.602.50%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -31.35% | -33.43% | 48.35% | 57.55% | 466.67% |
| Total Depreciation and Amortization | 0.66% | 15.04% | 7.73% | 5.28% | 12.08% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 116.02% | 81.50% | -70.17% | -11.00% | 22.48% |
| Change in Net Operating Assets | -87.90% | 223.97% | 17.53% | 64.71% | -306.14% |
| Cash from Operations | -18.67% | 49.50% | 13.12% | 4,325.60% | -97.89% |
| Capital Expenditure | -12.29% | -4.48% | 27.02% | 29.60% | 12.13% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 100.00% | -- | -- | -- | 90.68% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 129.03% | -114.26% | 2,587.56% | -691.18% | -99.93% |
| Cash from Investing | 98.43% | -353.18% | 806.82% | 89.88% | 62.56% |
| Total Debt Issued | -- | -- | -- | -- | -100.00% |
| Total Debt Repaid | -- | 100.00% | 37.50% | 38.46% | -306.50% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 219.70% | -237.50% | 112.12% | -1,115.38% | -65.49% |
| Cash from Financing | 219.70% | 97.31% | 44.22% | 31.96% | -176.14% |
| Foreign Exchange rate Adjustments | -275.47% | 436.51% | 45.45% | -148.23% | 266.90% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 422.27% | -125.13% | 3,306.12% | 101.98% | -275.27% |
